Skip to content
Home/Companies/Pharma/Karo Pharma (Karo Bio)

Karo Pharma (Karo Bio)

Pharma·Sweden·Exited 1998·Held 2yr
Entry
1996
Hold
2yr
Exit
1998

Who owns Karo Pharma (Karo Bio)?

Karo Pharma (Karo Bio) was owned by HealthCap through HealthCap (early funds) (1996 vintage) from 1996 to 1998, exited via IPO.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap (early funds) · 1996 · VC

Key facts

HQSweden
SectorPharma
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
1998

More from HealthCap (early funds)

Other portfolio companies in the same fund.

Affibody AB
Active
BiotechSweden· 2001
Pharmion Corp.
Exited 2003
PharmaUS· 2001
Gyros AB
Exited 2016
MedTechSweden· 2000
to
Cytos Biotechnology AG
Exited 2002
BiotechSwitzerland· 1999
Actelion Holding Ltd
Exited 2017
PharmaSwitzerland· 1997
to
Biotage AB (Pyrosequencing AB)
Exited 2000
BiotechSweden· 1997

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Karo Pharma (Karo Bio)

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Karo Pharma (Karo Bio)?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Karo Pharma (Karo Bio).

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue